Clinical Trial Update: A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome [Phase 2]

View source ↗

Summary

A Phase IIa randomized, double-blind trial comparing naproxen to aspirin for cancer immune interception in Lynch syndrome, with a focus on colorectal cancer-rel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Lynch Syndrome

Drugs mentioned

• Aspirin (Aspirin)
• Naproxen (Naproxen)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: T Cells, Colorectal Cancer | Phase 2 | Status: RECRUITING